Global Retirement Partners LLC acquired a new stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 80,578 shares of the real estate investment trust's stock, valued at approximately $1,724,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. WPG Advisers LLC lifted its stake in Healthpeak Properties by 270.2% in the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust's stock valued at $26,000 after buying an additional 1,197 shares in the last quarter. Advocate Investing Services LLC purchased a new position in Healthpeak Properties in the 4th quarter worth approximately $26,000. Clearstead Trust LLC lifted its stake in Healthpeak Properties by 66.7% in the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock worth $29,000 after purchasing an additional 543 shares in the last quarter. Elyxium Wealth LLC acquired a new position in shares of Healthpeak Properties during the 4th quarter worth approximately $31,000. Finally, Clearstead Advisors LLC boosted its holdings in shares of Healthpeak Properties by 166.3% during the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust's stock worth $31,000 after purchasing an additional 1,216 shares during the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.
Healthpeak Properties Price Performance
Healthpeak Properties stock opened at $20.60 on Tuesday. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The company has a fifty day simple moving average of $21.35 and a 200-day simple moving average of $18.93. The stock has a market cap of $14.20 billion, a P/E ratio of 58.86, a price-to-earnings-growth ratio of 3.20 and a beta of 1.01. Healthpeak Properties, Inc. has a 12-month low of $15.70 and a 12-month high of $22.95.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating the consensus estimate of $0.03 by $0.05. The firm had revenue of $771.58 million for the quarter, compared to analyst estimates of $725.64 million. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.Healthpeak Properties's revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities analysts expect that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The firm also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be paid a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.9%. Healthpeak Properties's payout ratio is presently 348.57%.
Analyst Ratings Changes
DOC has been the topic of a number of recent research reports. Wall Street Zen raised Healthpeak Properties from a "sell" rating to a "hold" rating in a research note on Sunday, May 10th. UBS Group raised their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the stock a "neutral" rating in a research report on Wednesday, July 8th. Royal Bank Of Canada boosted their target price on Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a research report on Monday, August 10th. Mizuho boosted their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a research note on Monday, July 6th. Finally, BMO Capital Markets upped their price objective on Healthpeak Properties from $20.00 to $24.00 and gave the stock an "outperform" rating in a research report on Monday, June 15th. Four analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company's stock. According to MarketBeat.com, Healthpeak Properties has an average rating of "Hold" and a consensus target price of $21.44.
View Our Latest Stock Report on DOC
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.